Cargando…
Lipid Metabolism and Lipid Droplets in Pancreatic Cancer and Stellate Cells
Pancreatic ductal adenocarcinoma (PDAC) is projected to become the second deadliest cancer by 2030, and the overall 5-year survival rate is currently less than 7%. Cancer cells frequently exhibit reprogramming of their metabolic activity. It is increasingly recognized that aberrant de novo lipid syn...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5789353/ https://www.ncbi.nlm.nih.gov/pubmed/29295482 http://dx.doi.org/10.3390/cancers10010003 |